J. Goldman & Co’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.54M | Buy |
+164,278
| New | +$3.54M | 0.08% | 175 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 307 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 311 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 224 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 233 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 235 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 255 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 229 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 239 |
|
|
2021
Q2 | – | Sell |
-8,647
| Closed | -$223K | – | 298 |
|
|
2021
Q1 | $223K | Buy |
+8,647
| New | +$223K | 0.01% | 304 |
|
|
2019
Q2 | – | Sell |
-15,644
| Closed | -$420K | – | 161 |
|
|
2019
Q1 | $420K | Buy |
+15,644
| New | +$420K | 0.02% | 150 |
|
|
2018
Q3 | – | Sell |
-123,769
| Closed | -$1.89M | – | 149 |
|
|
2018
Q2 | $1.89M | Buy |
+123,769
| New | +$1.89M | 0.1% | 130 |
|